THE EXAMINATION OF THE EFFECTS OF PPAR-A (RS4253778) ON SERUM LIPIDS IN ELITE CROSS-COUNTRY SKIERS
Öz
The purpose of this study was to examine the effects of PPAR-a (rs4253778) on serum lipids in elite cross-country skiers. This study included 34 cross-country skiers (23 males and 11 females who participated in the Turkish skiing national team camp). Genotyping for the PPAR-a gene rs4253778 G/C polymorphism was performed by PCR on Tercyk multicanal amplificator and restriction enzyme digestion. Statistical analysis was done by using the SPSS 22.0 package program. Genotypic frequency of the PPAR-a polymorphism was detected in cross-country skiers. PPAR-a GG, GC and CC genotypes were detected as 67.64%, 23.52% and 8.82%, respectively in 34 cross-country skiers while PPAR-a GG, GC and CC genotypes were detected as 47.05%, 16.64%, and 2.94%, respectively in elite males. PPAR-a GG, GC and CC genotypes were detected as 20.58 %, 5.88%, and 5.88%, respectively in females. PPAR-a G and C allele were detected as 49 and 19, respectively in 34 elite endurance athletes. In the present study, the GG genotypes were detected at higher frequencies in elite athletes (67.64% respectively) than GC and CC (23.52% and 8.82%, respectively). The difference between the PPAR-a G/C gene polymorphism of Turkish elite cross-country skiers and serum total cholesterol, HDL- cholesterol, LDL- cholesterol and TG levels was not statistically significant. Although there was not any statistically significant difference between the PPAR-a G/C gene polymorphism and lipid profiles of Turkish elite cross-country skiers, it is foreseen that PPAR-α genes have an important effect on endurance performance in sports requiring endurance such as cross-country skiing.
Anahtar Kelimeler
Cross-Country athletes, Lipids, PPAR-A Gene polymorphism, Sports
Kaynakça
- Ahmetov, I.I., Mozhayskaya, I.A., Flavell, D.M., Astratenkova, I.V., Komkova, A.I., Lyubaeva, E.V., Tarakin, P.P., Shenkman, B.S., Vdovina, A.B., Netreba, A.I., Popov, D.V., Vinogradova, O.L., Montgomery, H.E., Rogozkin, V.A. (2006). PPARalpha gene variation and physical performance in Russian athletes. European Journal of Applied Physiology, 97(1), 103–108. doi: 10.1007/s00421-006-0154-4
- Ahmetov, I., Egorova, E.S., Mustafina, L.J. (2013). The PPARa gene polymorphism in team sports athletes. Central European Journal of Sport Sciences and Medicine, 1, 19-24.
- Amir, O., Amir, R., Yamin, C., Attias, E., Eynon, N., Sagiv, M., Sagiv, M., Meckel, Y. (2007). The ACE deletion allele is associated with Israeli elite endurance athletes. Experimental Physiology, 92(5), 881–886. doi: 10.1113/expphysiol.2007.038711
- Barjaktarović-Labović S., Andrejević V., Banjari I., Kurgaš H., Zejnilović M. (2015). Lipid Status of Professıonal Athletes. MD-Medical Data, 7(1), 21-25.
- Berger, J., Moller, D. E. (2002). The mechanisms of action of PPARs. Annual Review of Medicine, 53, 409–435. doi: 10.1146/annurev.med.53.082901.104018
- Bray, M.S., Hagberg, J.M., Pérusse, L., Rankinen, T., Roth, S.M., Wolfarth, B., Bouchard, C. (2009). The human gene map for performance and health-related fitness phenotypes: the 2006-2007 update. Medicine and Science in Sports and Exercise, 41(1), 35–73. doi:10.1249/mss.0b013e3181844179
- Corak, A., Kapici, S., Sercan, C., Akkoç, O., Ulucan, K. (2017). A pilot study for determination of anxiety related SLC6A4 promoter "S" and "L" alleles in healthy Turkish athletes. Cellular and Molecular Biology (Noisy-le-Grand, France), 63(5), 29–31. doi: 10.14715/cmb/2017.63.5.6
- Eynon, N., Meckel, Y., Sagiv, M., Yamin, C., Amir, R., Sagiv, M., Goldhammer, E., Duarte, J.A., Oliveira, J. (2010). Do PPARGC1A and PPARalpha polymorphisms influence sprint or endurance phenotypes?. Scandinavian Journal of Medicine & Science in Sports, 20(1), e145–e150. doi: 10.1111/j.1600-0838.2009.00930.x
- Flavell, Jamshidi, Hawe, Torra, Taskinen, Frick, Nieminen, Kesäniemi, Pasternack, Staels, Miller, Humphries, Talmud, Syvänne. (2002). Peroxisome proliferator-activated receptor α gene variants influence progression of coronary atherosclerosis and risk of coronary artery disease. Circulation, 105, 1440–1445. doi: 10.1161/01.cir.0000012145.80593.25
- Hautala, A.J., Leon, A.S., Skinner, J.S., Rao, D.C., Bouchard, C., Rankinen, T. (2007). Peroxisome proliferator-activated receptor-delta polymorphisms are associated with physical performance and plasma lipids: the HERITAGE Family Study. American journal of physiology. Heart and Circulatory Physiology, 292(5), H2498–H2505. doi: 10.1152/ajpheart.01092.2006